Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Tampa General Circle
Suite 6005 STC
Tampa, FL 33606Phone+1 813-259-8512Fax+1 813-259-8593
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1999 - 2002
- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1995 - 1999
- Yale School of MedicineClass of 1995
Certifications & Licensure
- TX State Medical License 2000 - 2026
- FL State Medical License 2018 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Start of enrollment: 2020 Jul 23
- Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers Start of enrollment: 2019 Feb 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 261 citationsProteogenomic Characterization of Endometrial Carcinoma.Yongchao Dou, Emily Kawaler, Daniel Cui Zhou, Marina A. Gritsenko, Chen Huang
Cell. 2020-02-20 - 12 citationsAssociation Between Metabolic Syndrome and Endometrial Cancer Survival in a SEER-Medicare Linked Database.Jingxiao Jin, Shraddha M. Dalwadi, Ramya P. Masand, Tracilyn R. Hall, Matthew L. Anderson
American Journal of Clinical Oncology. 2020-06-01 - 6 citationsAdipose-derived exosomal miR-421 targets CBX7 and promotes metastatic potential in ovarian cancer cells.Yi Zhang, Roslyn Tedja, Michael Millman, Terrence Wong, Alexandra Fox
Journal of Ovarian Research. 2023-11-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: